Aditxt Inc. (ADTX)
Market Closed
23 Feb, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
0. 51
+0
+0.57%
$
10.91K Market Cap
- P/E Ratio
- Div Yield
160,195 Volume
-42.18 Eps
$ 0.51
Previous Close Day Range
0.5 0.53
Year Range
0.5 2,542.5
Want to track ADTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ADTX earnings report is expected in 78 days (13 May 2026)
Biotech News: Why Is Aditxt (ADTX) Stock Up 49% Today?
Aditxt (NASDAQ: ADTX ) stock is rising higher on Wednesday after the company notified investors of an update on a clinical trial conducted by its subsidiary Pearsanta. According to a press release from Aditxt, Pearsanta has submitted a Clinical Trial Translational Endpoints Research Award proposal to the Congressionally Directed Medical Research Programs (CDMRP) of the Department of Defense.
Investorplace | 1 year ago
Why Is Aditxt (ADTX) Stock Up 72% Today!
Aditxt (NASDAQ: ADTX ) stock is up on Wednesday after the biotech company announced an amended and restated merger agreement with Evofem Biosciences (OTCMKTS: EVFM ). Aditxt notes that the merger agreement was amended and restated as Evofem Biosciences has some critical needs ahead of it.
Investorplace | 1 year ago
